AWARENESS

The general public doesn’t realize the magnitude of problems faced by children and adolescents with cancer and those who survive their cancers.  The Awareness Interest Group seeks to shine the spotlight on facts, such as:

  • Childhood cancer is the leading cause of death by disease among children and adolescents in the United States.
  • Most causes of childhood cancer are unknown and not preventable.
  • The incidence of childhood cancer is on the increase.
  • Most survivors will experience significant debilitating complications that result from their treatment regimes.
  • Children and adolescents who have or have had cancer are much more likely (more than 60%) to face bullying than their healthy classmates.
  • Only four drugs have been developed and approved to treat a pediatric cancer in the last quarter century.

CAC2 member organizations with an interest in Awareness are encouraged to participate in the work of the CAC2 Advocacy and Awareness Interest Group. Notes from the 2019 meeting of the working group are available here. Email if you would like more information on how to be involved with CAC2 awareness initiatives.

Raising awareness is crucial to increasing research funds and legislative efficacy.
Collaborating amplifies our impact.

Latest CAC2 and Community News

CAC2 Childhood Cancer Community News Digest (March 11-17)

Assorted News from the Last Week: Feature story about CAC2 Member Beat Childhood Cancer and new FDA approved therapeutic DFMO:  Families of paediatric cancer patients have helped move a pioneering treatment for neuroblastoma from the lab to the clinic. Could ...

CAC2 Childhood Cancer Community News Digest (March 4-10)

Assorted News from the Last Week: Cancer Grand Challenges has selected five new global research teams that will address the following challenges in cancer.  This year two teams working to develop drugs for solid tumors in children were selected.  The ...

CAC2 Childhood Cancer Community News Digest (February 26-March 3)

Assorted News from the Last Week: Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada. President’s Cancer Panel Initial Assessment of the National Cancer Plan: A Report to the President of the United States Remembering ...